[HTML][HTML] NUP98–HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice

E Kroon, U Thorsteinsdottir, N Mayotte… - The EMBO …, 2001 - embopress.org
The EMBO journal, 2001embopress.org
Here we describe hemopoietic chimeras serving as a mouse model for NUP98–HOXA9‐
induced leukemia, which reproduced several of the phenotypes observed in human
disease. Mice transplanted with bone marrow cells expressing NUP98–HOXA9 through
retroviral transduction acquire a myeloproliferative disease (MPD) and eventually succumb
to acute myeloid leukemia (AML). The NUP98 portion of the fusion protein was shown to be
responsible for transforming a clinically silent pre‐leukemic phase observed for Hoxa9 into a …
Abstract
Here we describe hemopoietic chimeras serving as a mouse model for NUP98–HOXA9‐induced leukemia, which reproduced several of the phenotypes observed in human disease. Mice transplanted with bone marrow cells expressing NUP98–HOXA9 through retroviral transduction acquire a myeloproliferative disease (MPD) and eventually succumb to acute myeloid leukemia (AML). The NUP98 portion of the fusion protein was shown to be responsible for transforming a clinically silent pre‐leukemic phase observed for Hoxa9 into a chronic, stem cell‐derived MPD. The co‐expression of NUP98–HOXA9 and Meis1 accelerated the transformation of MPD to AML, identifying a genetic interaction previously observed for Hoxa9 and Meis1. Our findings demonstrate the presence of overlapping yet distinct molecular mechanisms for MPD versus AML, illustrating the complexity of leukemic transformation.
embopress.org